| Group A | Group B | Wilcoxon W/t/X2 | P |
---|---|---|---|---|
Patients with P elevation on day of administraition day n(%) | 15.4% (10/65) | 7.7% (5/65) | 1.884 | 0.170 |
RecFSH | 1275 (0,2700) | 1350 (787.52175) | −0.703 | 0.482 |
RecFSH/day | 137.5 (0,225) | 142.5 (98.44,197.73) | −1.735 | 0.083 |
Recovery rate of eggs | 13 (1,28) | 12 (3,34) | −1.516 | 0.129 |
Duration of GN(day) | 9 (6,19) | 9 (7,13) | −1.293 | 0.196 |
Fertilized egg number | 8.72 ± 4.26 | 8.63 ± 4.15 | 0.132 | 0.895 |
Fertilization rate | 69.2% (0,100%) | 78.5% (0,100%) | −1.493 | 0.135 |
Number of cleavage | 8.57 ± 4.23 | 8.53 ± 4.19 | 0.051 | 0.959 |
Cleavage rate | 100% (100,100%) | 100% (100,100%) | Â | Â |
High-quality embryo | 5 (0,13) | 6 (0,14) | −0.879 | 0.379 |
Rate of production of high-quality embryos | 60% (0,100%) | 70% (0,100%) | −1.21 | 0.226 |
P on the day of hCG administration (ng/mL) | 1.05 (0.3,2.61) | 0.95 (0.15,2.06) | −2.047 | 0.041 |
E2 on the day of hCG administration (pg/mL) | 1404.28 (431.36227) | 2867 (1043.62,7198) | −7.131 | < 0.001 |
P/E2 on the day of hCG administration | 0.73 (0.066,1.86) | 0.317 (0.043,1.84) | −6.931 | < 0.001 |
E2 on 1 day before the day of hCG administration | 546.95 (0,2611) | 1102 (0,5488) | −2.055 | 0.040 |
P on 1 day before the day of hCG administration | 0.545 (0,1.65) | 0.52 (0,1.83) | −0.33 | 0.741 |
P on 6th day post-ET (ng/mL) | 9.025 (0,96.3) | 9.08 (0,44.86) | −0.407 | 0.984 |
E2 on 6th day post-ET (ng/mL) | 103.4 (0,4737) | 127.75 (0,2656) | −0.158 | 0.875 |
Thickness of endometrium | 12.1 (9,17) | 12.2 (8.3,17.8) | −0.284 | 0.776 |
Clinical pregnancy rate | 53.1% (26/49) | 72.9% (35/48) | 4.096 | 0.043 |
Implantation rate | 35.1% (33/94) | 47.4% (45/95) | 2.931 | 0.087 |
Incidence of OHSS | 0% (0/65) | 1.5% (1/65) | 1.008 | 1.000 |
Live birth rate | 42.9% (21/49) | 62.5% (30/48) | 3.752 | 0.053 |
First trimester miscarriage | 7.7% (2/26) | 5.7% (2/35) | 0.095 | 1.000 |
Second trimester miscarriage | 7.7% (2/26) | 5.7% (2/35) | 0.095 | 1.000 |